Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification

Journal of Headache and Pain

Volumn 10, Issue 4, 2009, Pages 227-233

  Charles, James A ^a   Peterlin, B L ^b   Rapoport, Alan M ^c   Linder, Steven L ^d   Kabbouche, Marielle A ^e   Sheftell, Fred D ^f  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Dallas Pediatric Neurology   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adolescent; Child; Disease modification; Migraine

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; DEXAMETHASONE; DIHYDROERGOTAMINE; FLUNARIZINE; HYDROXYZINE; METOPROLOL; PROPRANOLOL; SEROTONIN; SUBSTANCE P; TRIPTAN DERIVATIVE;

ABSENTEEISM; ADOLESCENCE; ALLODYNIA; BEDTIME DOSAGE; BRAIN DAMAGE; BRAIN INFARCTION; CHILDHOOD; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG MECHANISM; EARLY INTERVENTION; EVIDENCE BASED MEDICINE; HEADACHE; HUMAN; MIGRAINE; MIGRAINE WITH AURA; MORBIDITY; NEUROPATHOLOGY; ONSET AGE; PRIORITY JOURNAL; REVIEW; SENSITIZATION; TRANSFORMED MIGRAINE; TRIGEMINAL NUCLEUS;

ADOLESCENT; AGE OF ONSET; AGING; ANALGESICS; BRAIN STEM; CHILD; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; MIGRAINE DISORDERS; RISK FACTORS; TREATMENT OUTCOME; TRIGEMINAL NERVE;

EID: 67650535667     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-009-0133-3     Document Type: Review

References (47)

1. Abu-Arefeh I, Russell G (1994) Prevalence of headache and migraine in school children. Br Med J 309:765-769
2. Split W, Newman W (1999) Epidemiology of migraine among students from randomly selected secondary schools in Lodz. Headache 39:494-501
3. Monastero R, Camarda C, Pipia C, Camarda R (2006) Prognosis of migraine headaches in adolescents. Neurology 67:1353-1356
4. Linder SL (2005) Do children and adolescents have chronic daily headache? Yes!. Curr Pain Headache Rep 9(5):358-362
5. Hershey A et al (2001) Characterization of chronic daily headaches in children in a multidisciplinary headache center. Neurology 56:1032-1037
6. Stewart WF, Lipton RB, Celentano DD et al (1992) Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 267(1):64-69
7. Stewart WF, Shechter A, Rasmussen BK (1994) Migraine prevalence. A review of population-based studies. Neurology 44(6 Suppl 4):S17-S23
8. Welch KMA, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache 106:81-89
9. Kruit MC, van Buchem MA, Hofman PA et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427
10. Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81-89
11. Kabbouche MA et al (2005) Outcome of a multidisciplinary approach to pediatric migraine at 1, 2, and 5 years. Headache 45:1298-1303
12. Charles JA, Jotkowitz S (2005) Observations of the "carry-over effect" following successful termination of chronic migraine in the adolescent with short-term dihydroergotamine, dexamethasone and hydroxyzine: A pilot study. J Headache Pain 6(1):51-54
13. Hering-Hanit R, Cohen A, Horev Z (2001) Successful withdrawal from analgesic abuse in a group of youngsters with chronic daily headache. J Child Neurol 16:448-449
14. Raskin NH, Hosobucki Y, Lamb S (1987) Headache may arise from perturbation of brain. Headache 27:416-420
15. Haas DC, Kent PF, Friedman DI (1993) Headache caused by a single lesion of multiple sclerosis in the periaqueductal grey area. Headache 33:452-455
16. Lipton R, Pan J (2004) Is migraine a progressive brain disease? JAMA 291:493-494
17. Marcus D (2003) Central sensitization: An important factor in the pathogenesis of chronic headache. Headache Pain 14(1):19-23
18. D'Amico D, Moschiano F, Bussone G (2006) Early treatment of migraine attacks with triptans: A strategy to enhance outcomes and patient satisfaction? Expert Rev Neurother 6(7):1087-1097
19. Silberstein SD (2008) Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine. Neurology 71:114-121
20. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47:614-624
21. Burstein R et al (2004) Defeating migraine pain with triptans: The race against the development of cutaneous allodynia. Ann Neurol 55(1):19-26
22. Waeber C, Moskowitz MA (2003) Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology 61:S9-S20
23. Mathew NT, Kailasam J, Seifert T (2004) Clinical recognition of allodynia in migraine. Neurology 63:848-852
24. Bille B (1997) A 40-year follow-up of school children with migraine. Cephalalgia 17(4):488-491
25. Ferrari A et al (2007) Similarities and differences between chronic migraine and episodic migraine. Headache 47(1):65-72
26. Wober C, Wober-Bingol C, Koch G, Wessely P (1991) Long-term results of migraine prophylaxis with flunarizine and beta-blockers. Cephalalgia 11(6):251-256
27. Solomon S, Lipton R, Newman L (1992) Clinical features of chronic daily headache. Headache 32(7):325-329
28. Mathew NT et al (1987) Transformed or evolutive migraine. Headache 27(2):102-106
29. Fries JF, Williams CA, Morfeld D, Singh G, Sibley J (1996) Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum 39(4):616-622
30. Fuller G, Bone I (2001) Disease modifying treatment in multiple sclerosis. J Neurol Neurosurg Psychiatry 71(Suppl 1):iI20-ii21
31. Fox A (2008) Disease modification in migraine: Study design and sample size implications. Headache 48(8):1169-1175
32. Fanicullace M, DeCesaris F (2005) Preventing chronicity of migraine. J Headache Pain 6(4):331-333
33. Petrella R, Speechley M, Kleinstiver P, Ruddy T (2005) Impact of a social marketing media campaign on public awareness of hypertension. Am J Hypertens 18(2):270-275
34. Loder D, Biondi D (2007) Disease modification in migraine: A concept that has come of age? Headache 43(2):135-143
35. Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression (or for chronic daily headaches) - clinical lessons. Headache 46(Suppl 3):S144-S146
36. Boardman HF, Thomas E, Millson DS, Croft PR (2006) The natural history of headache: Predictors of onset and recovery. Cephalalgia 9:1080-1088
37. Hershey A et al (2009) Obesity in the pediatric headache population: A multicenter study. Headache 49:170-177
38. Scher AI, Midgette LA, Lipton RB (2008) Risk factors for headache chronification. Headache 48(1):16-25
39. Peterlin L, Calhoun A, Siegel S, Mathew N (2008) Rational combination therapy in refractory migraine. Headache 48(6):805-819
40. Silberstein SD, Goadsby PJ (2002) Migraine: Preventive treatment. Cephalalgia 22:491-512
41. Brandes JL, Kudrow D, Stark SR, O'Carroll P, Adelman JU, O'Donnell FJ, Alexander AJ, Spruill SE, Barrett PS, Lener SE (2007) Sumatriptan-naproxen for acute treatment of migraine - a randomized trial. JAMA 297:1443-1454
42. Ahoen K et al (2006) A randomized trial of rizatriptan in migraine attacks in children. Neurology 67:1135-1140
43. Linder SL (1994) Treatment of childhood headache with dihydroergotamine mesylate. Headache 34(10):578-584
44. Winner P et al (2000) A randomized, double blind, placebo controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 106(5):989-997
45. Linder SL, Dowson A (2000) Zolmatriptan provides effective migraine relief in adolescents. Int J Clin Pract 54:466-469
46. Charles JA (2006) Almotriptan in the acute treatment of migraine in patients 11-17 years old - a study of efficacy and safety. J Headache Pain 7:95-97
47. Pageler L, Katsarava Z, Limmroth V et al (2004) Prednisone in the treatment of medication withdrawal headache following medication overuse headache: A placebo-controlled, double-blind, and randomized pilot study. Cephalalgia 24:792